Why is there a white ring around my iris?

A white ring around your iris, called arcus senilis or corneal arcus, is typically caused by cholesterol deposits in the cornea. While usually harmless in older adults, it can signal high cholesterol and cardiovascular risk in people under 40.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What Is the White Ring Around Your Iris?

If you've noticed a white, gray, or bluish ring forming around the colored part of your eye (the iris), you're observing a condition called arcus senilis or corneal arcus. This ring appears at the edge of the cornea, the clear front surface of your eye, where it meets the white part (sclera). The ring typically starts as an arc at the top and bottom of the cornea before eventually forming a complete circle.

Corneal arcus is one of the most common age-related changes in the eye, affecting approximately 60% of people over age 50 and nearly 100% of those over 80. The ring itself is composed of lipid (fat) deposits, primarily cholesterol and triglycerides, that accumulate in the peripheral cornea. While the appearance might be concerning, the condition doesn't affect vision since the deposits form at the cornea's edge rather than in the central visual axis.

Understanding the Science Behind Corneal Arcus

The formation of corneal arcus involves complex interactions between your blood vessels, cholesterol metabolism, and corneal tissue. The cornea is normally avascular (lacking blood vessels), but tiny blood vessels at the limbus (the border between the cornea and sclera) can leak lipids into the peripheral corneal tissue. These lipids, particularly cholesterol esters and phospholipids, gradually accumulate in the corneal stroma, the thick middle layer of the cornea.

Corneal Arcus: Age, Risk, and Clinical Significance

Risk assessment based on age of corneal arcus onset. Data compiled from multiple epidemiological studies.
Age GroupPrevalenceCardiovascular RiskRecommended Action
Under 40Under 40<5%4x higher risk of heart diseaseImmediate comprehensive lipid testing and cardiovascular assessment
40-5040-5020-30%2x higher risk if presentLipid panel and risk stratification within 1-2 months
50-6050-6050-60%Mild increased riskStandard cardiovascular screening
Over 60Over 60>80%No significant additional riskRoutine age-appropriate screening

Risk assessment based on age of corneal arcus onset. Data compiled from multiple epidemiological studies.

The deposits appear white or grayish because of how light scatters when it hits these lipid particles. Interestingly, there's typically a clear zone between the ring and the limbus called the lucid interval of Vogt, which remains free of deposits. This occurs because the limbal blood vessels create a barrier that prevents lipids from depositing immediately adjacent to them.

The clinical significance of corneal arcus depends heavily on your age. In people over 50, it's considered a normal aging change called arcus senilis. However, when it appears in younger individuals (under 40), it's termed arcus juvenilis and warrants medical investigation. Studies show that premature corneal arcus in younger adults correlates strongly with lipid abnormalities and increased cardiovascular disease risk.

The Cholesterol Connection

While corneal arcus in older adults doesn't always indicate high cholesterol, there's a significant association between the two, especially in younger individuals. Research published in the British Medical Journal found that people under 50 with corneal arcus had a 4-fold increased risk of having elevated cholesterol levels compared to those without the condition. The relationship becomes even more pronounced in people under 40, where corneal arcus almost always indicates dyslipidemia (abnormal lipid levels).

The specific lipid abnormalities most commonly associated with corneal arcus include elevated LDL cholesterol (the 'bad' cholesterol), high triglycerides, and low HDL cholesterol (the 'good' cholesterol). Additionally, elevated apolipoprotein B (ApoB), a protein that carries cholesterol in the blood, shows a strong correlation with corneal arcus development. Understanding your complete lipid profile through comprehensive testing can help identify these risk factors early.

The following table shows the relationship between age, corneal arcus, and cardiovascular risk based on current medical literature.

Familial Hyperlipidemia and Genetic Factors

Corneal arcus can be an important clinical sign of familial hyperlipidemia, a genetic condition causing extremely high cholesterol levels from birth. People with familial hypercholesterolemia (FH) often develop corneal arcus in their 20s or 30s, decades earlier than the general population. If you have corneal arcus and a family history of early heart disease or high cholesterol, genetic testing and aggressive cholesterol management may be necessary.

When Should You See a Doctor?

The urgency of seeking medical attention for corneal arcus depends on several factors. If you're under 40 and notice a white ring developing around your iris, schedule an appointment with your healthcare provider promptly. This age group has the highest correlation between corneal arcus and systemic lipid disorders. Even if you're over 50, it's worth discussing corneal arcus with your doctor during your next check-up, especially if you haven't had recent cholesterol screening.

  • Under 40 years old: See a doctor within 2-4 weeks for comprehensive lipid testing
  • 40-50 years old: Discuss at your next routine appointment and request cholesterol screening
  • Over 50 with no recent cholesterol test: Schedule cholesterol screening within 3 months
  • Any age with family history of heart disease: Seek evaluation within 2-4 weeks
  • Accompanied by chest pain or other cardiac symptoms: Seek immediate medical attention

Associated Symptoms to Watch For

While corneal arcus itself doesn't cause symptoms, it may appear alongside other signs of high cholesterol or cardiovascular disease. Be alert for xanthomas (yellowish cholesterol deposits on the skin), xanthelasma (yellow patches on the eyelids), chest pain, shortness of breath, or leg pain when walking. These symptoms, combined with corneal arcus, suggest more advanced cardiovascular disease requiring immediate evaluation.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Tests and Monitoring

If you have corneal arcus, your doctor will likely recommend a comprehensive lipid panel to assess your cardiovascular risk. This should include not just basic cholesterol measurements but also advanced markers like ApoB, lipoprotein(a), and inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP). These advanced biomarkers provide a more complete picture of your cardiovascular health than traditional cholesterol tests alone.

Regular monitoring becomes crucial once corneal arcus is identified, especially in younger individuals. The American Heart Association recommends lipid screening every 4-6 years for adults with normal risk, but those with corneal arcus under age 50 should consider annual testing. For comprehensive cardiovascular and metabolic health monitoring, at-home testing programs can provide convenient, regular assessments of key biomarkers.

Beyond lipid testing, your doctor may recommend additional cardiovascular assessments such as blood pressure monitoring, electrocardiogram (ECG), carotid ultrasound, or coronary calcium scoring, particularly if you have multiple risk factors or premature corneal arcus.

Treatment and Management Strategies

It's important to understand that corneal arcus itself doesn't require treatment and won't affect your vision. The ring is permanent once formed and doesn't respond to cholesterol-lowering therapy. However, addressing the underlying lipid abnormalities that may have contributed to its formation is crucial for preventing cardiovascular disease.

Lifestyle Modifications

The foundation of managing high cholesterol associated with corneal arcus involves comprehensive lifestyle changes. Dietary modifications should focus on reducing saturated fat intake to less than 7% of total calories, eliminating trans fats, and increasing soluble fiber consumption to 10-25 grams daily. The Mediterranean diet pattern, rich in olive oil, nuts, fish, and vegetables, has shown particular effectiveness in improving lipid profiles.

  • Exercise regularly: Aim for at least 150 minutes of moderate-intensity aerobic activity weekly
  • Maintain healthy weight: Even a 5-10% weight loss can significantly improve cholesterol levels
  • Quit smoking: Smoking lowers HDL cholesterol and damages blood vessels
  • Limit alcohol: Excessive alcohol can raise triglyceride levels
  • Manage stress: Chronic stress can negatively impact cholesterol metabolism

Medical Interventions

When lifestyle changes aren't sufficient, medication may be necessary, especially for those with premature corneal arcus or familial hyperlipidemia. Statins remain the first-line therapy for lowering LDL cholesterol, with studies showing 20-60% reductions depending on the specific medication and dose. Other options include ezetimibe (which blocks cholesterol absorption), PCSK9 inhibitors (for severe cases or statin intolerance), and fibrates or omega-3 fatty acids for high triglycerides.

The treatment approach and intensity depend on your overall cardiovascular risk, which includes factors beyond just corneal arcus and cholesterol levels. The following table outlines treatment recommendations based on risk categories.

Other Conditions That Can Cause Eye Rings

While corneal arcus is the most common cause of a white ring around the iris, other conditions can create similar appearances. Kayser-Fleischer rings, caused by copper deposits in Wilson's disease, appear as golden-brown or greenish rings and require immediate medical attention. These rings typically appear in younger people and are accompanied by neurological symptoms like tremors or difficulty with coordination.

Limbal rings, the dark circles that naturally border the iris in many people, are different from corneal arcus. These are a normal anatomical feature, often more prominent in younger individuals, and tend to fade with age. Unlike corneal arcus, limbal rings are darker than the iris and don't indicate any health concerns.

Band keratopathy, characterized by calcium deposits across the central cornea, creates a horizontal white band rather than a ring. This condition is associated with chronic eye inflammation, kidney disease, or elevated blood calcium levels and can affect vision, unlike corneal arcus.

Living with Corneal Arcus: Long-term Outlook

The prognosis for individuals with corneal arcus varies significantly based on age of onset and associated risk factors. For those over 60, corneal arcus without other cardiovascular risk factors doesn't significantly impact life expectancy. However, people under 50 with corneal arcus have a statistically higher risk of cardiovascular events, making aggressive risk factor modification essential.

Long-term management focuses on cardiovascular risk reduction rather than the corneal arcus itself. Regular monitoring of lipid levels, blood pressure, and other cardiovascular risk markers becomes part of routine health maintenance. Many people with corneal arcus who maintain healthy cholesterol levels and lifestyle habits experience no cardiovascular complications.

For those interested in comprehensive health monitoring and understanding their cardiovascular risk factors, consider uploading your existing blood test results to SiPhox Health's free analysis service. This service provides personalized insights and actionable recommendations based on your unique biomarker profile, helping you track progress over time and make informed decisions about your health.

Taking Action for Your Heart Health

Discovering a white ring around your iris can be an important wake-up call for your cardiovascular health, especially if you're under 50. While the ring itself is harmless and won't affect your vision, it serves as a visible reminder of the importance of maintaining healthy cholesterol levels and overall cardiovascular wellness. By understanding what corneal arcus means for your health, getting appropriate testing, and taking proactive steps to manage your risk factors, you can use this early warning sign to your advantage in preventing future cardiovascular disease.

References

  1. Fernández, A., Sorokin, A., & Thompson, P. D. (2007). Corneal arcus as coronary artery disease risk factor. Atherosclerosis, 193(2), 235-240.[PubMed][DOI]
  2. Chambless, L. E., Fuchs, F. D., Linn, S., et al. (1990). The association of corneal arcus with coronary heart disease and cardiovascular disease mortality in the Lipid Research Clinics Mortality Follow-up Study. American Journal of Public Health, 80(10), 1200-1204.[PubMed]
  3. Moss, S. E., Klein, R., & Klein, B. E. (2000). Arcus senilis and mortality in a population with diabetes. American Journal of Ophthalmology, 129(5), 676-678.[PubMed][DOI]
  4. Ang, M., Wong, W., Park, J., et al. (2011). Corneal arcus is a sign of cardiovascular disease, even in low-risk persons. American Journal of Ophthalmology, 152(5), 864-871.[PubMed][DOI]
  5. Chua, J., Tham, Y. C., Tan, B., et al. (2017). Age-related changes of individual macular retinal layers among Asians. Scientific Reports, 7(1), 1-10.[PubMed][DOI]
  6. Zech, L. A., & Hoeg, J. M. (2008). Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia. Lipids in Health and Disease, 7(1), 7.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my cholesterol at home?

You can test your cholesterol at home with SiPhox Health's Apob Advanced Cholesterol Panel, which includes comprehensive lipid testing including ApoB, LDL-C, HDL-C, and triglycerides, providing lab-quality results from the comfort of your home.

Is corneal arcus reversible with treatment?

No, corneal arcus is permanent once formed and won't disappear even if cholesterol levels are normalized. However, treating underlying high cholesterol is crucial for preventing cardiovascular disease, even though it won't remove the ring.

At what age is corneal arcus considered normal?

Corneal arcus is generally considered a normal aging change in people over 50-60 years old. However, if it appears before age 40, it's called arcus juvenilis and strongly suggests underlying lipid abnormalities requiring medical evaluation.

Can corneal arcus affect my vision?

No, corneal arcus doesn't affect vision because the lipid deposits form at the edge of the cornea, outside the visual axis. The condition is purely cosmetic and doesn't cause any visual symptoms or require eye treatment.

What's the difference between corneal arcus and cataracts?

Corneal arcus is a white ring of cholesterol deposits at the edge of the cornea that doesn't affect vision, while cataracts are a clouding of the eye's lens that causes progressive vision loss. They're completely different conditions with different causes and treatments.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details